ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 78 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $19,000 | -58.7% | 53,271 | +74.0% | 0.00% | – |
Q1 2018 | $46,000 | -31.3% | 30,624 | -34.8% | 0.00% | – |
Q4 2017 | $67,000 | -11.8% | 46,961 | +42.3% | 0.00% | – |
Q3 2017 | $76,000 | +406.7% | 33,000 | +192.0% | 0.00% | – |
Q2 2017 | $15,000 | -93.4% | 11,300 | -89.3% | 0.00% | – |
Q1 2017 | $227,000 | -42.7% | 106,037 | +17.8% | 0.00% | – |
Q4 2016 | $396,000 | -17.5% | 90,044 | -9.0% | 0.00% | – |
Q3 2016 | $480,000 | +879.6% | 98,989 | +610.5% | 0.00% | – |
Q1 2016 | $49,000 | – | 13,933 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 289,664 | $434,000 | 0.43% |
SALZHAUER MICHAEL | 220,153 | $330,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $2,467,000 | 0.08% |
Brown Advisory Securities, LLC | 272,000 | $408,000 | 0.08% |
Par Capital Management | 4,431,301 | $6,647,000 | 0.07% |
ISTHMUS PARTNERS, LLC | 176,170 | $264,000 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 96,429 | $145,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 262,544 | $394,000 | 0.02% |
Ballentine Partners, LLC | 100,000 | $150,000 | 0.01% |
NWAM LLC | 20,000 | $30,000 | 0.01% |